Saturday, April 28 - Tuesday, May 1, 2001
Baltimore Convention Center

Jointly sponsored by the
American Pediatric Society, Society for Pediatric Research,
and Ambulatory Pediatric Association

In cooperation with
The Center for Continuing Education,
Tulane University Medical Center

NEPHROLOGY

Saturday, 4/28/2001

9:15 AM-12:00 PM - Mini Course

u Update in the Genetics of Renal and Liver Tumors in Childhood
Chair: Gail Tomlinson, University of Texas Southwestern Medical Center, Dallas, TX

This course will provide up-to-date information on genetics and epidemiology of renal and liver tumors in children, including Wilms tumor and hepatoblastoma. We will discuss recent findings in germ-line mutations and familial associations. The course will inform the clinician of the emerging association of hepatoblastoma and premature and low-birth weight infants and introduce strategies for cancer surveillance in the high-risk child.

Genetics of Wilms Tumor
Max J. Coppes, Alberta Children's Hospital, Alberta, Canada

Cytogenetics of Renal and Liver Tumors in Children
Nancy R. Schneider, University of Texas Southwestern Medical Center, Dallas, TX

Cancer Surveillance for Overgrowth Syndromes
Michael R. DeBaun, Washington University School of Medicine, St. Louis, MO

Hepatoblastoma and Prematurity
James Feusner, Children's Hospital, Oakland, CA

Sponsored jointly with the American Society of Pediatric Hematology/Oncology

3:15 PM-5:15 PM - Platform Session

u Molecular Basis of Renal Development and Disease

5:15 PM-7:15 PM - Poster Session I

u Cell Injury
u Clinical Nephrology: Chronic Renal Insufficiency
u Clinical Nephrology: Disease Models
u Cytokines and Cell Signaling
u Renal Development

Sunday, 4/29/2001

8:00 AM-10:00 AM - Topic Symposium

u Steroid-Resistant Nephrotic Syndrome: New Advances and Insights
Chairs: William E. Smoyer, University of Michigan Medical Center, Ann Arbor, MI and H. William Schnaper, Northwestern University, Chicago, IL

Steroid-resistant nephrotic syndrome is one of the most common forms of primary nephrotic syndrome in childhood. Recent genetic and molecular studies indicate that the podocyte plays a central role in the pathogenesis of this disorder. This symposium will address recent advances in our understanding of the development, cell biology, and pathology of the glomerular podocyte. The recent identification of NPHS2, the gene encoding the glomerular protein podocin, and its role in autosomal recessive steroid-resistant nephrotic syndrome will be discussed. Finally, new strategies for therapeutic intervention in steroid-resistant nephrotic syndrome will be described.

Development of the Glomerular Capillary Wall
Dale R. Abrahamson, University of Kansas Medical Center, Kansas City, KS

Cell Biology and Pathology of Podocytes
Peter Mundel, Albert Einstein College of Medicine, Bronx, NY

The Genetic Basis of Steroid-Resistant Nephrotic Syndrome
Corinne Antignac, INSERM, Paris, France

Therapeutic Interventions for Steroid-Resistant Nephrotic Syndrome
Frederick J. Kaskel, Albert Einstein College of Medicine, Bronx, NY

Sponsored jointly with the American Society of Pediatric Nephrology

10:15 AM-11:45 AM

u APS Plenary/Howland Award & (11:15 AM) St. Geme Award

EVENING

APS Member Dinner in Honor of the Howland Award Recipient

Tuesday, 5/1/2001

10:15 AM-11:15 AM - State of the Art Plenary

u The Human Genome Project
Chair: Alan M. Krensky, Stanford University Medical Center, Stanford, CA

The Human Genome Project is impacting every aspect of medicine. Dr. Craig Venter, President of Celera Genomics, one of the chief architects of this venture, will discuss the accomplishments of the human genome project and implications for future impact on health and disease in this special one-hour state of the art lecture.

Sequencing the Human Genome
J. Craig Venter, President, Celera Genomics, Rockville, MD

Supported in part by an educational grant from the Columbus Children's Hospital, Columbus, OH

 

COMPLETE DAILY SCHEDULE:

Last Modified: July 23, 2002